Metraipolis › archive › dc_f827bf201025

Efficacy and safety of TACE/HAIC combined with targeted immunotherapy versus targeted immunotherapy for advanced hepatocellular carcinoma: a meta-analysis — Europe PMC PMID:41347074

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41347074
DOI
10.3389/fonc.2025.1669460
License (as archived)
solo-consultazione
Archived
2026-11-08T10:21:11.229Z
SHA-256 of the archived text
38319d0ca5a204365b88cb56dc2ed863ed82a8f6d0cb9ccf1feb51c772037201
Stable URL of this page
https://metraipolis.com/documento/dc_f827bf201025

How to cite

Efficacy and safety of TACE/HAIC combined with targeted immunotherapy versus targeted immunotherapy for advanced hepatocellular carcinoma: a meta-analysis — Europe PMC PMID:41347074 — Europe PMC (en), https://europepmc.org/article/MED/41347074 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f827bf201025 (Metraipolis archive dc_f827bf201025, sha256 38319d0ca5a204365b88cb56dc2ed863ed82a8f6d0cb9ccf1feb51c772037201)
BibTeX
@misc{dcf827bf201025,
  title = {Efficacy and safety of TACE/HAIC combined with targeted immunotherapy versus targeted immunotherapy for advanced hepatocellular carcinoma: a meta-analysis — Europe PMC PMID:41347074},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41347074},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f827bf201025; sha256 38319d0ca5a204365b88cb56dc2ed863ed82a8f6d0cb9ccf1feb51c772037201},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347074. Agents can read the archived copy with the MCP tool read_document.